These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8534589)

  • 1. 111In-octreotide scintigraphy: a tool to select patients with endocrine pancreatic tumors for octreotide treatment?
    Keymeulen B; Bossuyt A; Peeters TL; Somers G
    Ann Nucl Med; 1995 Aug; 9(3):149-52. PubMed ID: 8534589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.
    Shi W; Buchanan KD; Johnston CF; Larkin C; Ong YL; Ferguson R; Laird J
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):303-9. PubMed ID: 9578820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
    Leners N; Jamar F; Fiasse R; Ferrant A; Pauwels S
    J Nucl Med; 1996 Jun; 37(6):916-22. PubMed ID: 8683311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
    Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
    Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
    Angeletti S; Corleto VD; Schillaci O; Marignani M; Annibale B; Moretti A; Silecchia G; Scopinaro F; Basso N; Bordi C; Delle Fave G
    Gut; 1998 Jun; 42(6):792-4. PubMed ID: 9691916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatostatin receptor-based imaging and therapy of digestive endocrine tumors].
    Illouz F; Sadoul JL; Rohmer V
    Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S3-12. PubMed ID: 21237328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
    Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
    Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP
    Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
    Modlin IM; Cornelius E; Lawton GP
    Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 111In-octreotide scintigraphy in metastatic medullary thyroid carcinoma before and after octreotide therapy: in vivo evidence of the possible down-regulation of somatostatin receptors.
    Ronga G; Salerno G; Procaccini E; Mauro L; Annovazzi A; Barone R; Mellozzi M; Tamburrano G; Signore A
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):134-6. PubMed ID: 9002772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The visualization of gastroenteropancreatic endocrine tumors.
    Lamberts SW; Chayvialle JA; Krenning EP
    Metabolism; 1992 Sep; 41(9 Suppl 2):111-5. PubMed ID: 1355584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
    Breeman WA; van Hagen PM; Kwekkeboom DJ; Visser TJ; Krenning EP
    Eur J Nucl Med; 1998 Feb; 25(2):182-6. PubMed ID: 9473268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
    Van Eijck CH
    Br J Surg; 2005 Nov; 92(11):1333-4. PubMed ID: 16237740
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma.
    Cuvelier C; Pochet JM; Col V; Jonard P; Pauwels S; Cuvelier A
    Acta Clin Belg; 1994; 49(6):296-301. PubMed ID: 7871936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.
    Ferone D; Pivonello R; Lastoria S; Faggiano A; Del Basso de Caro ML; Cappabianca P; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):469-77. PubMed ID: 11318782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors.
    Oda Y; Tanaka Y; Naruse T; Sasanabe R; Tsubamoto M; Funahashi H
    Surg Today; 2002; 32(8):690-4. PubMed ID: 12181718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.